These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 920655)

  • 1. Effect of hyperchylomicronemia on the measurement of hemoglobin.
    Gagné C; Auger PL; Moorjani S; Brun D; Lupien PJ
    Am J Clin Pathol; 1977 Nov; 68(5):584-6. PubMed ID: 920655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased hemoglobin-oxygen affinity in patients with pancreatitis associated with type I and V hyperlipoproteinemia.
    Ditzel J; Thaysen EH
    Adv Exp Med Biol; 1977 Jul 4-7; 94():423-8. PubMed ID: 26174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical, biochemical, and familial presentation of type V hyperlipoproteinemia in childhood.
    Kwiterovich PO; Farah JR; Brown WV; Bachorik PS; Baylin SB; Neill CA
    Pediatrics; 1977 Apr; 59(4):513-25. PubMed ID: 191790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 16-hour-standing test and lipoprotein electrophoresis compared for detection of chylomicrons in plasma.
    McNeely S; Seatter K; Yuhaniak J; Kashyap ML
    Clin Chem; 1981 May; 27(5):731-2. PubMed ID: 7226497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oxyhemoglobin dissociation curve in patients with familial hyperchylomicronemia.
    Ditzel J; Dyerberg J
    J Lab Clin Med; 1977 Mar; 89(3):573-80. PubMed ID: 618355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fat-induced hyperchylomicronemia in a 16-year-old Arab boy.
    Keinan Z; Tamir I; Dickerman Z; Stein JA
    Isr J Med Sci; 1973 Feb; 9(2):185-9. PubMed ID: 4696153
    [No Abstract]   [Full Text] [Related]  

  • 7. [Type-V-hyperlipoproteinemia].
    Heckers H; Oehler G
    Med Welt; 1975 Sep; 26(39):1766-74. PubMed ID: 170491
    [No Abstract]   [Full Text] [Related]  

  • 8. Postprandial plasma triglyceride and cholesterol responses to a low-fat meal.
    Olefsky JM; Crapo P; Reaven GM
    Am J Clin Nutr; 1976 May; 29(5):535-9. PubMed ID: 178167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial hyperchylomicronemia. Enzymatic and physiologic studies.
    Ford S; Schubert WK; Glueck CJ; Bozian RC
    Am J Med; 1971 Apr; 50(4):536-41. PubMed ID: 5572597
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia.
    Krauss RM; Levy RI; Fredrickson DS
    J Clin Invest; 1974 Nov; 54(5):1107-24. PubMed ID: 4370795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte membrane lipid composition in exogenous and endogenous hypertriglyceridemia.
    Bagdade JD; Ways PO
    J Lab Clin Med; 1970 Jan; 75(1):53-60. PubMed ID: 5410499
    [No Abstract]   [Full Text] [Related]  

  • 12. Transient lipoprotein lipase deficiency with hyperchylomicronemia.
    Goldberg IJ; Paterniti JR; Franklin BH; Ginsberg HN; Ginsberg-Fellner F; Brown WV
    Am J Med Sci; 1983; 286(2):28-31. PubMed ID: 6614044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertriglyceridemia in patients with chronic renal insufficiency.
    McCosh EJ; Solangi K; Rivers JM; Goodman A
    Am J Clin Nutr; 1975 Sep; 28(9):1036-43. PubMed ID: 1163470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Typing of hyperlipoproteinemia in an Israel hospital.
    Eisenberg S
    Isr J Med Sci; 1976 Nov; 12(11):1261-8. PubMed ID: 1017927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lymphoproliferation by hyperlipoproteinemic plasma.
    Waddell CC; Taunton OD; Twomey JJ
    J Clin Invest; 1976 Oct; 58(4):950-4. PubMed ID: 184112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperlipoproteinemia type V Fredrickson. A rare metabolic disorder, its diagnosis and therapy, as demonstrated on an own case].
    Wessels G
    Med Welt; 1977 Jan; 28(3):136-7. PubMed ID: 190520
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia.
    Joven J; Vilella E
    Clin Nephrol; 1997 Sep; 48(3):141-5. PubMed ID: 9342484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.
    Brunzell JD; Hazzard WR; Porte D; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1578-85. PubMed ID: 4352459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and function of anti-lipoprotein lipase auto-antibodies in type V hyperchylomicronemia.
    Moret M; Pruneta-Deloche V; Sassolas A; Marcais C; Moulin P
    Atherosclerosis; 2010 Feb; 208(2):324-7. PubMed ID: 19695572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
    Weisweiler P; Schwandt P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():398-401. PubMed ID: 206058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.